Collateral for a security interest recorded Jun 19, 2020 (Armistice Capital Master Fund Ltd.).
Term ended Sep 15, 2024 · High confidence
20-year base term ended Sep 15, 2024
Held by Reshape Lifesciences Inc.
Filed Jun 19, 2009 as application 12/488,421 · Granted Aug 30, 2011
Base term, 20 years from filing
Today
Term ended Sep 15, 2024
2004
2026
Clock starts
Sep 15, 2004
Sep 15, 2004
Term ended
Sep 15, 2024
Sep 15, 2024
Granted
Aug 30, 2011
Aug 30, 2011
base term
after the term ends
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
14
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. All three maintenance fees were paid, so no fee lapse ended it. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 15, 2004, when application PCT/US2004/030053, the earliest non-provisional in its chain, was filed (this one was filed Jun 19, 2009) | Sep 15, 2024 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Sep 15, 2024 | High confidence |
This family
| US 7,901,381 | In force Jul 2028 | Jul 2028 |
| US 7,762,998 | In force Feb 2028 | Feb 2028 |
| US 7,947,011 | Term ended Sep 2024 | Sep 2024 |
| US 7,972,315 | Term ended Sep 2024 | Sep 2024 |
| US 8,007,465 | Term ended Sep 2024 | Sep 2024 |
| US 7,811,275 | Term ended Sep 2024 | Sep 2024 |
| US 8,007,479 | this patent Sep 2024 | Sep 2024 |
| US 7,892,200 | Term ended Sep 2024 | Sep 2024 |
8 of 14 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 22, 2013 Reel 31455, frame 656 | Birk, Janel A.; Coe, Frederick L.; Hoyt, Robert E., JR | Allergan, Inc. | Assignment of Assignor's Interest |
| Dec 2, 2013 Reel 31747, frame 761 | Allergan, Inc. | Apollo Endosurgery, Inc. | Assignment of Assignor's Interest |
| Dec 3, 2013 Reel 31756, frame 729 | Apollo Endosurgery, Inc. | Oxford Finance LLC, as Agent | Security Agreement |
| Mar 2, 2015 Reel 35120, frame 740 | Oxford Finance LLC, as Agent | Apollo Endosurgery, Inc. | Termination of Patent Security Interest (Recorded on 12/3/13 at Reel/Frame 031756/0729 and on 1/2/14 at Reel/Frame 031910/0460) |
| Mar 2, 2015 Reel 35120, frame 843 | Apollo Endosurgery, Inc. | Athyrium Opportunities II Acquisition LP, as Administrative Agent | Notice of Grant of Security Interest in Patents |
| Dec 30, 2016 Reel 41224, frame 821 | Apollo Endosurgery US, Inc. | Athyrium Opportunities II Acquisition LP, as Administrative Agent | Notice of Grant of Security Interest in Patents |
| Mar 27, 2017 Reel 42106, frame 912 | Apollo Endosurgery, Inc. | Apollo Endosurgery US, Inc. | Change of Name |
| Jan 4, 2019 Reel 48012, frame 902 | Athyrium Opportunities II Acquisition LP, as Administrative Agent | Apollo Endosurgery US, Inc. | Termination and Release of Security Interest in Patents |
| Apr 15, 2019 Reel 48885, frame 687 | Apollo Endosurgery US, Inc. | Solar Capital Ltd., as Collateral Agent | Intellectual Property Security Agreement |
| Aug 12, 2019 Reel 50031, frame 549 | Apollo Endosurgery US, Inc. | Reshape Lifesciences Inc. | Assignment of Assignor's Interest |
| Jun 18, 2020 Reel 52994, frame 686 | Solar Capital Ltd. | Apollo Endosurgery US, Inc. | Release of Security Interest |
| Jun 19, 2020 Reel 52987, frame 463 | Reshape Lifesciences Inc.; Reshape Medical LLC | Armistice Capital Master Fund Ltd. | Security Interest |
| Dec 30, 2021 Reel 58599, frame 297 | SLR Investment Corp. (F/K/A Solar Capital Ltd.) | Apollo Endosurgery US, Inc.; Apollo Endosurgery International, LLC; Apollo Endosurgery, Inc.; Lpath Therapeutics Inc. | Release of Security Interest |
| Dec 30, 2021 reel/frame not recorded | SLR Investment Corp. (F/K/A Solar Capital Ltd.) | Apollo Endosurgery US, Inc. | Release of Security Interest |
| Dec 30, 2021 reel/frame not recorded | SLR Investment Corp. (F/K/A Solar Capital Ltd.) | Apollo Endosurgery International, LLC | Release of Security Interest |
| Dec 30, 2021 reel/frame not recorded | SLR Investment Corp. (F/K/A Solar Capital Ltd.) | Apollo Endosurgery, Inc. | Release of Security Interest |
| Dec 30, 2021 reel/frame not recorded | SLR Investment Corp. (F/K/A Solar Capital Ltd.) | Lpath Therapeutics Inc. | Release of Security Interest |
| Oct 24, 2024 Reel 70166, frame 882 | Reshape Lifesciences Inc. | Ascent Partners Fund LLC | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Citations
1,052
later US patents cite this one
That is top 1% of utility patents granted in 2011 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.